Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Transl Oncol ; 25(4): 873-881, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-36417084

RESUMEN

Platelet-derived microvesicles (PMVs), the microvesicles with the highest concentration in the bloodstream, play a key role in the regulation of hemostasis, inflammation, and angiogenesis. PMVs have recently been identified as key factors in the link between platelets and cancer. PMVs bind to both cancer cells and nontransformed cells in the microenvironment of the tumor, and then transfer platelet-derived contents to the target cell. These contents have the potential to either stimulate or modulate the target cell's response. PMVs are encased in a lipid bilayer that contains surface proteins and lipids as well as components found inside the PMV. Each of these components participates in known and potential PMV roles in cancer. The complicated roles played by PMVs in the onset, development, and progression of cancer and cancer-related comorbidities are summarized in this study.


Asunto(s)
Micropartículas Derivadas de Células , Neoplasias , Humanos , Plaquetas , Micropartículas Derivadas de Células/metabolismo , Neoplasias/metabolismo , Microambiente Tumoral
2.
Clin Transl Oncol ; 24(12): 2319-2329, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-35962918

RESUMEN

Acute myeloid leukemia (AML) is an aggressive type of blood cancer affecting bone marrow (BM). In AML, hematopoietic precursors are arrested in the early stages of development and are defined as the presence of ≥ 20% blasts (leukemia cells) in the BM. Toll-like receptors (TLR) are major groups of pattern recognition receptors expressed by almost all innate immune cells that enable them to detect a wide range of pathogen-associated molecular patterns and damage-associated molecular patterns to prime immune responses toward adaptive immunity. Because TLRs are commonly expressed on transformed immune system cells (ranging from blasts to memory cells), they can be a potential option for developing efficient clinical alternatives in hematologic tumors. This is because several in vitro and in vivo investigations have demonstrated that TLR signaling increased the immunogenicity of AML cells, making them more vulnerable to T cell-mediated invasion. This study aimed to review the current knowledge in this field and provide some insight into the therapeutic potentials of TLRs in AML.


Asunto(s)
Leucemia Mieloide Aguda , Moléculas de Patrón Molecular Asociado a Patógenos , Receptores Toll-Like , Adyuvantes Inmunológicos , Humanos , Leucemia Mieloide Aguda/tratamiento farmacológico , Receptores de Reconocimiento de Patrones , Transducción de Señal , Receptores Toll-Like/agonistas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA